{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.196.12.1501",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2021-02-11T10:17:19.000-05:00"
  },
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h3>Value Set Contents</h3><p>This value set contains 20 concepts</p><p>All codes from system <code>http://www.nlm.nih.gov/research/umls/rxnorm</code></p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1037234\"> </a>1037234</td><td>benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1046770\"> </a>1046770</td><td>12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1046787\"> </a>1046787</td><td>atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1046815\"> </a>1046815</td><td>atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1046982\"> </a>1046982</td><td>hyoscyamine sulfate 0.125 MG Sublingual Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1046985\"> </a>1046985</td><td>hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1046997\"> </a>1046997</td><td>atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1047786\"> </a>1047786</td><td>hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1047881\"> </a>1047881</td><td>hyoscyamine sulfate 0.025 MG/ML Oral Solution</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1047895\"> </a>1047895</td><td>hyoscyamine sulfate 0.125 MG/ML Oral Solution</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1047905\"> </a>1047905</td><td>hyoscyamine sulfate 0.125 MG Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1047916\"> </a>1047916</td><td>1 ML hyoscyamine sulfate 0.5 MG/ML Injection</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1048124\"> </a>1048124</td><td>12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1048307\"> </a>1048307</td><td>hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1048336\"> </a>1048336</td><td>hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1050325\"> </a>1050325</td><td>hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1087365\"> </a>1087365</td><td>hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1440869\"> </a>1440869</td><td>hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-1807886\"> </a>1807886</td><td>Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet</td></tr><tr><td style=\"white-space:nowrap\"><a name=\"http---www.nlm.nih.gov-research-umls-rxnorm-998726\"> </a>998726</td><td>hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule</td></tr></table></div>"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1501",
  "version": "20180310",
  "name": "Hyoscyamine",
  "status": "active",
  "date": "2018-03-10T01:00:08-05:00",
  "publisher": "NCQA PHEMUR",
  "expansion": {
    "identifier": "urn:uuid:6f6cdd7c-ac27-4d0f-bd73-a187bd786c82",
    "timestamp": "2022-07-19T15:10:05-04:00",
    "total": 20,
    "offset": 0,
    "parameter": [ {
      "name": "count",
      "valueInteger": 1000
    }, {
      "name": "offset",
      "valueInteger": 0
    } ],
    "contains": [ {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1037234",
      "display": "benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1046770",
      "display": "12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1046787",
      "display": "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1046815",
      "display": "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1046982",
      "display": "hyoscyamine sulfate 0.125 MG Sublingual Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1046985",
      "display": "hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1046997",
      "display": "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1047786",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1047881",
      "display": "hyoscyamine sulfate 0.025 MG/ML Oral Solution"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1047895",
      "display": "hyoscyamine sulfate 0.125 MG/ML Oral Solution"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1047905",
      "display": "hyoscyamine sulfate 0.125 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1047916",
      "display": "1 ML hyoscyamine sulfate 0.5 MG/ML Injection"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1048124",
      "display": "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1048307",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1048336",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1050325",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1087365",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1440869",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "1807886",
      "display": "Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet"
    }, {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version": "07142022",
      "code": "998726",
      "display": "hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule"
    } ]
  }
}